Now it makes sense why they are really squeezing budgets. It doesn’t bode well for jobs there. I spoke to some neighbours who work at another Pharma company and they are laying off too.
Wait a min…if the patent expired, is it a copycat? It’s really curios to see copycat and generic in the website preview. Further down the text, there is no explanation at all of why the terms are interchanged.
According to its own earlier statements, the pharmaceutical group will experience the heaviest burden from copycat drugs in its history in the coming months because the billion-euro drugs Entresto, Promacta and Tasigna have lost their patent protection
.
I’ve always considered the terms interchangeable.
In my last company we were preparing for loss of patent protection for our blockbuster drug (and cash cow) for >5 years, so it was obviously no surprise. So I don’t expect Novartis to panic or make rash decisions like firing 000’s of highly trained, institutionalised staff members… unless of course they want to use this as an excuse to downsize.
1 Like